Lisa M. Almond - Publications

Physiologically Based Pharmacokinetic Modeling of Vitamin B-12 Incorporating Mechanistic Absorption: An Example Application for Intake Estimation During Pregnancy.

Journal: The Journal of nutrition

Published: April 29, 2025

PBPK-Led Assessment of Antimalarial Drug Concentrations in Breastmilk: A Strategy for Optimal Use of Prediction Methods to Guide Decision Making in an Understudied Population.

Journal: CPT: pharmacometrics & systems pharmacology

Published: August 29, 2024

Angiosarcoma: a 10-year retrospective study from a high-volume UK regional referral centre.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: June 10, 2024

A tutorial on physiologically based pharmacokinetic approaches in lactation research.

Journal: CPT: pharmacometrics & systems pharmacology

Published: June 04, 2024

Using PBPK modeling to supplement clinical data and support the safe and effective use of dolutegravir in pregnant and lactating women.

Journal: CPT: pharmacometrics & systems pharmacology

Published: May 03, 2024

Addressing health equity for breastfeeding women: primaquine for Plasmodium vivax radical cure.

Journal: Malaria journal

Published: May 02, 2024

PBPK-led assessment of antimalarial drugs as candidates for Covid-19: Simulating concentrations at the site of action to inform repurposing strategies.

Journal: Clinical and translational science

Published: December 12, 2023

Supplementing clinical lactation studies with PBPK modeling to inform drug therapy in lactating mothers: Prediction of primaquine exposure as a case example.

Journal: CPT: pharmacometrics & systems pharmacology

Published: July 30, 2023

Development and application of a PBPK modeling strategy to support antimalarial drug development.

Journal: CPT: pharmacometrics & systems pharmacology

Published: February 27, 2023

Risk Factors for the Development of Early Recurrence in Patients with Primary Retroperitoneal Sarcoma.

Journal: Annals of surgical oncology

Published: February 06, 2023

Safety of elexacaftor/tezacaftor/ivacaftor dose reduction: Mechanistic exploration through physiologically based pharmacokinetic modeling and a clinical case series.

Journal: Pharmacotherapy

Published: January 10, 2023

Physiologically Based Pharmacokinetic Modeling To Guide Management of Drug Interactions between Elexacaftor-Tezacaftor-Ivacaftor and Antibiotics for the Treatment of Nontuberculous Mycobacteria.

Journal: Antimicrobial agents and chemotherapy

Published: October 26, 2022